by Pete Celano | Jun 7, 2026 | Blog
THE FEHV: The Foundation for the Study of Viral Hepatitis is a leading international non-profit organization in the field of hepatology , with top specialists in liver diseases and molecular biology. At our clinic in Madrid, we treat all types of liver diseases...
by David Sires | Jun 6, 2026 | Blog
EASL has come and gone for the year and this article is a stellar summary: From EASL 2026: “What Hepatology Still Needs to Solve.” The AJMC article highlights a panel discussion among leading hepatologists about the biggest unresolved challenges facing the...
by Brandon Tudor | Jun 3, 2026 | Blog
The article, “A therapeutic turning point in metabolic liver disease” (npj Gut and Liver, June 2026), is an editorial that argues the field of metabolic liver disease has entered a new era, driven by clearer disease definitions, deeper mechanistic understanding, and...
by Pete Celano | Jun 1, 2026 | Blog
We will miss Tony Villiotti’s peerless innovation in moving liver disease in America from very low awareness among patients, payers and providers, to its current state of surging enthusiasm, energy and engagement.
by David Sires | May 31, 2026 | Blog
The 05/26/2026 article “The importance of reading your medical records when living with MASH” from Liver Disease News powered by Bionews highlights how reading your own medical records can be one of the most important tools for managing life with MASH...
by Brandon Tudor | May 28, 2026 | Blog
Roche announced a new “Liver Disease Panel,” which it says is the first certified suite of digital algorithms designed to help clinicians detect and manage chronic liver disease (CLD) earlier and more efficiently. Key points from the announcement: The panel focuses...
